Commission Implementing Regulation (EU) 2026/372 of 20 February 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, boscalid, dodine, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluometuron, fluopyram, flutolanil, geraniol, malathion, penoxsulam, pinoxaden, prohexadione, proquinazid, prosulfuron, pyrethrins, pyridaben, pyrimethanil, sintofen, spiroxamine, sulphur and thymol

Implementing Regulation (EU) 2026/372 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX 1. Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 June 2027’; (2) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 March 2028’; (3) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2027’; (4) in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘30 November 2027’; (5) in the sixth column, expiration of approval, of row 213, Fenpyroximate, the date is replaced by ‘31 January 2028’; (6) in the sixth column, expiration of approval, of row 246, Pyrethrins, the date is replaced by ‘30 April 2028’; (7) in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 July 2027’; (8) in the sixth column, expiration of approval, of row 300, Malathion, the date is replaced by ‘15 July 2028’; (9) in the sixth column, expiration of approval, of row 301, Penoxsulam, the date is replaced by ‘15 May 2027’; (10) in the sixth column, expiration of approval, of row 302, Proquinazid, the date is replaced by ‘31 December 2027’; (11) in the sixth column, expiration of approval, of row 313, Pyridaben, the date is replaced by ‘31 January 2030’; (12) in the sixth column, expiration of approval, of row 317, 6-benzyladenine, the date is replaced by ‘15 January 2030’; (13) in the sixth column, expiration of approval, of row 323, Dodine, the date is replaced by ‘30 June 2028’; (14) in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘30 June 2028’; (15) in the sixth column, expiration of approval, of row 335, Fluometuron, the date is replaced by ‘15 January 2030’; (16) in the sixth column, expiration of approval, of row 341, Sintofen, the date is replaced by ‘15 January 2030’; (17) in the sixth column, expiration of approval, of row 346, Aluminium sulfate, the date is replaced by ‘15 January 2030’. 2. Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 6, Prohexadione, the date is replaced by ‘15 May 2028’; (2) in the sixth column, expiration of approval, of row 7, Spiroxamine, the date is replaced by ‘30 November 2029’; (3) in the sixth column, expiration of approval, of row 12, 1-naphthylacetamide, the date is replaced by ‘30 November 2029’; (4) in the sixth column, expiration of approval, of row 13, 1-naphthylacetic acid, the date is replaced by ‘30 November 2029’; (5) in the sixth column, expiration of approval, of row 15, Fluazifop-P, the date is replaced by ‘30 November 2029’; (6) in the sixth column, expiration of approval, of row 45, Eugenol, the date is replaced by ‘15 April 2028’; (7) in the sixth column, expiration of approval, of row 46, Geraniol, the date is replaced by ‘15 April 2028’; (8) in the sixth column, expiration of approval, of row 47, Thymol, the date is replaced by ‘15 April 2028’; (9) in the sixth column, expiration of approval, of row 51, Fluopyram, the date is replaced by ‘15 June 2028’; (10) in the sixth column, expiration of approval, of row 97, Pinoxaden, the date is replaced by ‘31 December 2029’. 3. Part E of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 2, Esfenvalerate, the date is replaced by ‘30 November 2029’; (2) in the sixth column, expiration of approval, of row 6, Prosulfuron, the date is replaced by ‘15 December 2029’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview